SR One Capital Management, LP
Redwood City, CA · CIK 1910264 · 13F filing filed 2025-05-13
SEC-registered investment adviser since 2020 · limited partnership
- Assets managed$2.4bn
- Staff28 · 15 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds19 · $2.4bn gross assets
- Websitesrone.com
- Form ADV · 2026-03-31SEC adviser record
- Kindprivate equity
- Others nearbyRedwood City, CA, London
As an employer
- Offices in2 countries
- Private fundsprivate equity 19
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Redwood City, CA (main office)United States | about 10 |
| LondonUnited Kingdom | 5 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$389.3m
reported value
-5.1% vs Q4 2024
12positions
98.3%in top 10
1 new
1 added
0 reduced
0 sold out
vs Q4 2024
Holdings, Q1 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCELLX INC ACLX | $153.9m39.54% | Unchanged |
| ARS PHARMACEUTICALS INC SPRY | $50.5m12.97% | Unchanged |
| MINERALYS THERAPEUTICS INC MLYS | $49.7m12.76% | Added +1.1m |
| ZENAS BIOPHARMA INC ZBIO | $38.8m9.97% | Unchanged |
| CRISPR THERAPEUTICS AG CRSP | $35.7m9.17% | Unchanged |
| DESIGN THERAPEUTICS INC DSGN | $25.2m6.47% | Unchanged |
| ALUMIS INC ALMS | $12.0m3.09% | Unchanged |
| OCULIS HOLDING AG OCS | $6.1m1.58% | New |
| NKARTA INC NKTX | $6.1m1.58% | Unchanged |
| ORUKA THERAPEUTICS INC ORKA | $4.4m1.13% | Unchanged |
| KALA BIO INC COM NEW | $3.4m0.88% | Unchanged |
| ENGENE HOLDINGS INC COM | $3.3m0.86% | Unchanged |